Literature DB >> 30944608

A 10-year retrospective study of melanoma stage at diagnosis in the academic emergency hospital of Sibiu county.

Maria Rotaru1,2, Cristina Raluca Jitian2, Gabriela Mariana Iancu1,2.   

Abstract

Melanoma is considered to be the most aggressive skin cancer, with an increasing incidence worldwide. An accurate staging of melanoma is crucial in describing the cancer status, estimating prognosis and deciding the optimal treatment solution. In the present study, melanoma staging highlights the importance of early detection, most of the patients having been diagnosed with advanced stages of this skin cancer. A retrospective study was conducted among 117 patients of the Academic Emergency County Hospital of Sibiu, diagnosed with melanoma between 2007 and 2016. The staging of the patients with melanoma was made using the American Joint Committee on Cancer (AJCC) 7th edition, and reconsidered in the light of the AJCC 8th edition. The results showed that the majority of the cases had distant metastases, 40.17% were diagnosed with stage IV melanoma. 25.65% of the patients were diagnosed with stage III melanoma, having a regional disease. The rest of the cases had localized melanoma (stages I and II, 30.76%), while only 3.42% of them were diagnosed with melanoma in situ, the melanoma type with the greatest chances of survival. Analyzing the Breslow index, it was observed that the most common tumor thickness was 2.1 to 4 mm (34.19%). In conclusion, as the incidence of melanoma increases in Romania, further efforts are needed to improve the early detection of melanoma. There are hopes that with the correct and early diagnosis of melanoma, the mortality rate of this neoplasm will decrease in the future.

Entities:  

Keywords:  Breslow index; melanoma; prognosis; stage; tumor

Year:  2019        PMID: 30944608      PMCID: PMC6444339          DOI: 10.3892/ol.2019.10098

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  3 in total

Review 1.  Withaferin A-A Promising Phytochemical Compound with Multiple Results in Dermatological Diseases.

Authors:  Simona Bungau; Cosmin Mihai Vesa; Areha Abid; Tapan Behl; Delia Mirela Tit; Anamaria Lavinia Purza; Bianca Pasca; Laura Maghiar Todan; Laura Endres
Journal:  Molecules       Date:  2021-04-21       Impact factor: 4.411

2.  Risk factors for positive sentinel lymph node, lymphatic or hematogenous dissemination over time in patients with cutaneous melanoma.

Authors:  Alexandra S Berghe; Gheorghe Cobzac; George Dindelegan; Simona C Șenilă; Corina I Baican; Carolina M Solomon; Liliana Rogojan; Daniel C Leucuța; Tudor C Drugan; Sorana D Bolboacă
Journal:  Exp Ther Med       Date:  2021-05-05       Impact factor: 2.447

3.  Clinical-dermoscopic similarities between atypical nevi and early stage melanoma.

Authors:  Cristina-Raluca Jitian Mihulecea; Simona Frățilă; Maria Rotaru
Journal:  Exp Ther Med       Date:  2021-06-09       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.